Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors
US6541511B1 · kind B1 · utility
2Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2002 |
| Grant date | Apr 1, 2003 |
| Priority date | — |
| Expiry date | Jun 10, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel methyl analog of simvastatin, which has the ability to inhibit the synthesis of cholesterol. The compound of the present invention holds promise for the treatment and prophylaxis of hypercholesterolemia and of various cardiac disorders. The invention also relates to a process for making the novel compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.